Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein-protein interaction refers to the specific and intentional physical contact between two or more protein molecules, mediated by various non-covalent and sometimes covalent forces, to regulate almost every biological process in a cell or organism. PPIs can be stable (permanent complexes) or transient (signal transduction, enzymatic regulation), and are fundamental to processes such as signal transduction, gene regulation, immune response, cell cycle, and metabolism. Aberrant PPIs are implicated in diseases such as cancer and neurodegeneration, making individual PPIs attractive but challenging therapeutic targets. Experimentally, PPIs are studied via in vitro (e.g., co-immunoprecipitation), in vivo (e.g., yeast two-hybrid), and in silico (computational prediction) methods.
Inhibition or stabilization of a specific PPI, typically by blocking or enhancing the interface between the protein binding partners
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein-protein interaction (PPI).